99 related articles for article (PubMed ID: 26138656)
1. Angiotensin II receptor antagonist olmesartan and NF-kappaB inhibitor as cytotoxic and apoptotic agents in MCF-7 human cell line.
Bakhtiari E; Hosseini A; Boroushaki MT; Mousavi SH
J Chemother; 2016 Aug; 28(4):314-20. PubMed ID: 26138656
[TBL] [Abstract][Full Text] [Related]
2. Synergistic, cytotoxic and apoptotic activities of olmesartan with NF-κB inhibitor against HeLa human cell line.
Bakhtiari E; Hosseini A; Boroushaki MT; Mousavi SH
Toxicol Mech Methods; 2015; 25(8):614-21. PubMed ID: 26330000
[TBL] [Abstract][Full Text] [Related]
3. The role of ROS and NF-κB pathway in olmesartan induced-toxicity in HeLa and mcf-7 cell lines.
Bakhtiari E; Hosseini A; Mousavi SH
Biomed Pharmacother; 2017 Sep; 93():429-434. PubMed ID: 28666209
[TBL] [Abstract][Full Text] [Related]
4. [BAY11-7082 inhibits proliferation and promotes apoptosis in breast carcinoma MCF-7 cells by inhibiting phosphorylation of ATP citrate lyase].
Huang Y; Su M; Wei L; Ji F; Wang N; Zhong C; Chen T
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2015 Nov; 31(11):1458-62. PubMed ID: 26522351
[TBL] [Abstract][Full Text] [Related]
5. Novel angiotensin receptor blocker, azilsartan induces oxidative stress and NFkB-mediated apoptosis in hepatocellular carcinoma cell line HepG2.
Ahmadian E; Khosroushahi AY; Eftekhari A; Farajnia S; Babaei H; Eghbal MA
Biomed Pharmacother; 2018 Mar; 99():939-946. PubMed ID: 29710494
[TBL] [Abstract][Full Text] [Related]
6. NF-kappaB inhibition sensitizes to starvation-induced cell death in high-risk myelodysplastic syndrome and acute myeloid leukemia.
Fabre C; Carvalho G; Tasdemir E; Braun T; Adès L; Grosjean J; Boehrer S; Métivier D; Souquère S; Pierron G; Fenaux P; Kroemer G
Oncogene; 2007 Jun; 26(28):4071-83. PubMed ID: 17213804
[TBL] [Abstract][Full Text] [Related]
7. A nuclear factor-kappaB inhibitor BAY11-7082 inhibits interactions between human endothelial cells, T cells, and monocytes.
Zhu B; Liu Z; Wang P; Wu C; Xu H
Transplant Proc; 2008 Oct; 40(8):2724-8. PubMed ID: 18929846
[TBL] [Abstract][Full Text] [Related]
8. Suppression of diabetes-induced retinal inflammation by blocking the angiotensin II type 1 receptor or its downstream nuclear factor-kappaB pathway.
Nagai N; Izumi-Nagai K; Oike Y; Koto T; Satofuka S; Ozawa Y; Yamashiro K; Inoue M; Tsubota K; Umezawa K; Ishida S
Invest Ophthalmol Vis Sci; 2007 Sep; 48(9):4342-50. PubMed ID: 17724226
[TBL] [Abstract][Full Text] [Related]
9. Bortezomib inhibits nuclear factor-kappaB dependent survival and has potent in vivo activity in mesothelioma.
Sartore-Bianchi A; Gasparri F; Galvani A; Nici L; Darnowski JW; Barbone D; Fennell DA; Gaudino G; Porta C; Mutti L
Clin Cancer Res; 2007 Oct; 13(19):5942-51. PubMed ID: 17908991
[TBL] [Abstract][Full Text] [Related]
10. The pharmacological NF-κB inhibitor BAY11-7082 induces cell apoptosis and inhibits the migration of human uveal melanoma cells.
Hu S; Luo Q; Cun B; Hu D; Ge S; Fan X; Chen F
Int J Mol Sci; 2012 Nov; 13(12):15653-67. PubMed ID: 23443086
[TBL] [Abstract][Full Text] [Related]
11. [BAY11-7082 and Lactacystein in CD154-induced NF-kappaB activation].
Zhang X; Zhang W; Zeng XF; Zhang FC; Tang FL; Yu MX
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2004 Oct; 26(5):488-91. PubMed ID: 15562757
[TBL] [Abstract][Full Text] [Related]
12. Nuclear factor kappaB activity determines the sensitivity of kidney epithelial cells to apoptosis: implications for mercury-induced renal failure.
Dieguez-Acuña FJ; Polk WW; Ellis ME; Simmonds PL; Kushleika JV; Woods JS
Toxicol Sci; 2004 Nov; 82(1):114-23. PubMed ID: 15282405
[TBL] [Abstract][Full Text] [Related]
13. Angiotensin II receptor type 1 blockers suppress the cell proliferation effects of angiotensin II in breast cancer cells by inhibiting AT1R signaling.
Du N; Feng J; Hu LJ; Sun X; Sun HB; Zhao Y; Yang YP; Ren H
Oncol Rep; 2012 Jun; 27(6):1893-903. PubMed ID: 22426690
[TBL] [Abstract][Full Text] [Related]
14. SRS06, a new semisynthetic andrographolide derivative with improved anticancer potency and selectivity, inhibits nuclear factor-κB nuclear binding in the A549 non-small cell lung cancer cell line.
Lim JC; Jeyaraj EJ; Sagineedu SR; Wong WS; Stanslas J
Pharmacology; 2015; 95(1-2):70-7. PubMed ID: 25613753
[TBL] [Abstract][Full Text] [Related]
15. MKP1 repression is required for the chemosensitizing effects of NF-kappaB and PI3K inhibitors to cisplatin in non-small cell lung cancer.
Cortes-Sempere M; Chattopadhyay S; Rovira A; Rodriguez-Fanjul V; Belda-Iniesta C; Tapia M; Cejas P; Machado-Pinilla R; Manguan-García C; Sánchez-Pérez I; Nistal M; Moratilla C; de Castro-Carpeño J; Gonzalez-Barón M; Albanell J; Perona R
Cancer Lett; 2009 Dec; 286(2):206-16. PubMed ID: 19553005
[TBL] [Abstract][Full Text] [Related]
16. Effects of nuclear factor kappa B signaling pathway in human intervertebral disc degeneration.
Zhongyi S; Sai Z; Chao L; Jiwei T
Spine (Phila Pa 1976); 2015 Feb; 40(4):224-32. PubMed ID: 25494317
[TBL] [Abstract][Full Text] [Related]
17. Olmesartan blocks advanced glycation end products (AGEs)-induced angiogenesis in vitro by suppressing receptor for AGEs (RAGE) expression.
Yamagishi S; Matsui T; Nakamura K; Inoue H; Takeuchi M; Ueda S; Fukami K; Okuda S; Imaizumi T
Microvasc Res; 2008 Jan; 75(1):130-4. PubMed ID: 17560613
[TBL] [Abstract][Full Text] [Related]
18. Possible role of NF-ĸB signals in heat stress-associated increase in protein content of cultured C2C12 cells.
Ohno Y; Yamada S; Sugiura T; Ohira Y; Yoshioka T; Goto K
Cells Tissues Organs; 2011; 194(5):363-70. PubMed ID: 21422748
[TBL] [Abstract][Full Text] [Related]
19. NF-κB mediates the survival of corneal myofibroblast induced by angiotensin II.
Pan HW; Cui YH; Zeng JW
Invest Ophthalmol Vis Sci; 2014 Jun; 55(7):4220-8. PubMed ID: 24917146
[TBL] [Abstract][Full Text] [Related]
20. Olmesartan protects against oxidative stress possibly through the Nrf2 signaling pathway and inhibits inflammation in daunorubicin-induced nephrotoxicity in rats.
Gounder VK; Arumugam S; Arozal W; Thandavarayan RA; Pitchaimani V; Harima M; Suzuki K; Nomoto M; Watanabe K
Int Immunopharmacol; 2014 Feb; 18(2):282-9. PubMed ID: 24291173
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
